Peter Bains Steps Down As Biocon CEO, Takes Over As Syngene MD & CEO

Peter Bains has stepped down as the Chief Executive Officer (CEO) of Biocon Group, effective April 1, 2025, and will now serve as the Managing Director (MD) and CEO of Syngene International.

Bains has over 30 years of global experience in strategic and operational leadership, spanning biopharmaceuticals, branded generics, life sciences, and CROs. His role focuses on maximising value through collaboration in manufacturing, project execution, scientific expertise, and global best practices. He previously served as CEO and board member of Syngene, leading its public listing in 2015. His past roles include CEO of Sosei Group and senior leadership at GlaxoSmithKline. Bains holds a bachelor’s degree in science from the University of Sheffield, UK, and serves as a Non-Executive Director on multiple biotech company Boards.

a

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere:

This will close in 0 seconds